TIBER CREEK GROUP
TIBER CREEK GROUP filed a Q3 report for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) on October 20, 2025, reporting $70,000 in lobbying income.
Lobbying for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) · Biopharmaceutical company.
-
MATTHEW LEFFINGWELL New on this filingPreviously held: Mbr Servs & Coalitions Dir., House Approps Cmte (2016-2017); CoS, Rep. Kay Granger (2012-2015); Dep CoS, Rep. Granger (2010-2012); Comms Dir, Rep. Granger (2009-2010); Press Sec, Rep. Jon Porter (2007-2009); Projects Dir, Rep. Mark Kirk (2006-2007)
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to Centers for Medicare and Medicaid.